Related Experiment Video
Updated: Jun 30, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
Published on: October 10, 2025
MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage
Hideo Kobayashi1, Sharmila Chattopadhyay, Kinshi Kato
1Department of Anesthesiology, University of California, San Diego, CA 92093-0629, USA.
Abstract:
Matrix metalloproteinases (MMPs) emerge as modulators of neuropathic pain. Because myelin protects Abeta afferents from ectopic hyperexcitability and nociception from innocuous mechanical stimuli (or mechanical allodynia), we analyzed the role of MMPs in the development of mechanical allodynia through myelin protein degradation after rat and MMP-9-/- mouse L5 spinal nerve crush (L5 SNC). MMPs were shown to promote selective degradation of myelin basic protein (MBP), with MMP-9 regulating initial Schwann cell-mediated MBP processing after L5 SNC. Acute and long-term therapy with GM6001 (broad-spectrum MMP inhibitor) protected from injury-induced MBP degradation, caspase-mediated apoptosis, macrophage infiltration in the spinal nerve and inhibited astrocyte activation in the spinal cord. The effect of GM6001 therapy on attenuation of mechanical allodynia was robust, immediate and sustained through the course of L5 SNC. In conclusion, MMPs mediate the initiation and maintenance of mechanical nociception through Schwann cell-mediated MBP processing and support of neuroinflammation.
Insights
Matrix metalloproteinases (MMPs) drive neuropathic pain by degrading myelin basic protein (MBP). Inhibiting MMPs with GM6001 effectively reduces mechanical allodynia and neuroinflammation.
Area of Science:
- Neuroscience
- Pain Research
- Molecular Biology
Background:
- Neuropathic pain involves ectopic hyperexcitability and mechanical allodynia.
- Myelin sheath protects nerve fibers but can be degraded.
- Matrix metalloproteinases (MMPs) are implicated in pain modulation.
Purpose of the Study:
- To investigate the role of MMPs in mechanical allodynia development.
- To determine if MMPs degrade myelin proteins after spinal nerve injury.
- To evaluate the therapeutic potential of MMP inhibition.
Main Methods:
- Spinal nerve crush (SNC) model in rats and MMP-9 knockout mice.
- Analysis of myelin basic protein (MBP) degradation.
- Administration of GM6001, a broad-spectrum MMP inhibitor.
- Assessment of apoptosis, macrophage infiltration, and astrocyte activation.
Main Results:
- MMPs, particularly MMP-9, mediate the degradation of myelin basic protein (MBP) after L5 SNC.
- GM6001 treatment prevented MBP degradation, apoptosis, and neuroinflammation.
- GM6001 therapy provided immediate and sustained attenuation of mechanical allodynia.
Conclusions:
- MMPs initiate and maintain mechanical nociception via MBP processing.
- MMP inhibition is a promising therapeutic strategy for neuropathic pain.
- Targeting MMPs can reduce neuroinflammation associated with nerve injury.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Nociception
Mechanically-gated Ion Channels
Neurogenesis and Regeneration of Nervous Tissue
